Bank of New York Mellon Corp - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 102 filers reported holding MAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$1,058,846
-32.9%
339,374
-1.3%
0.00%
Q2 2023$1,578,166
-99.0%
343,827
+3.0%
0.00%
-100.0%
Q1 2023$161,005,486
+8943.9%
333,887
-1.3%
0.04%
Q4 2022$1,780,273
-17.9%
338,282
+1.4%
0.00%
-100.0%
Q3 2022$2,169,000
+69.7%
333,773
+23.6%
0.00%
Q2 2022$1,278,000
-39.3%
270,082
-10.3%
0.00%
Q1 2022$2,105,000
-38.3%
301,173
-10.0%
0.00%
-100.0%
Q4 2021$3,411,000
+282.0%
334,780
+357.5%
0.00%
Q3 2021$893,00073,1760.00%
Other shareholders
MAXCYTE INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,885,000$5,881,2005.55%
Vitruvian Partners LLP 5,043,356$15,735,2714.46%
Stonepine Capital Management, LLC 3,761,640$11,736,3173.90%
Mudita Advisors LLP 1,390,858$4,339,4773.17%
RIVER GLOBAL INVESTORS LLP 1,473,254$4,588,3591.07%
Casdin Capital, LLC 1,890,000$5,896,8000.65%
Portolan Capital Management 2,143,666$6,688,2380.62%
Grandeur Peak Global Advisors, LLC 1,434,819$4,476,6350.34%
First Light Asset Management, LLC 1,073,110$3,348,1030.32%
Granahan Investment Management 1,975,847$6,164,6430.22%
View complete list of MAXCYTE INC shareholders